In addition, the crucial proteins of the PTGS2 signaling pathway such as AKT, STK33, and MTOR were all elevated in COX-2-driven HCC; thus, targeting these proteins could active these oncogenic cascades by COX-2 overexpression during the pathogenesis of HCC [30]. This evidence concerns the gene STK33 and hepatocellular carcinoma.